Clinical Trial Update: Study Evaluating The Safety And Efficacy Of Varenicline and Bupropion For Smoking Cessation In Subjects With And Without A History Of Psychiatric Disorders [Phase 4]

View source ↗

Summary

Phase 4 study evaluating the safety and efficacy of varenicline and bupropion for smoking cessation in people with and without a history of psychiatric disorder…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Tobacco Use Disorder

Drugs mentioned

• Varenicline (varenicline)
• bupropion (bupropion)

Snippet

Sponsor: Pfizer | Conditions: Smoking Cessation | Phase 4 | Status: COMPLETED | Results posted: 2016-05-02